Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antiplatelet Treatment in Diabetes
ISRCTN79817966Phase 3Completed
- Sponsor
- University of Leeds
- Start
- May 2010
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
01
Overview
Phase 3, randomised, open-label trial of clopidogrel, prasugrel and aspirin in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by University of Leeds. Started May 2010; status: completed.
02
Drugs
clopidogrelprasugrelaspirin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on ISRCTN79817966.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN79817966.